Moleculin Biotech, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Moleculin Biotech, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Moleculin Biotech, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $39K, a 14.7% increase year-over-year.
  • Moleculin Biotech, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $130K, a 12.2% decline year-over-year.
  • Moleculin Biotech, Inc. annual Operating Lease, Payments for 2023 was $134K, a 3.88% increase from 2022.
  • Moleculin Biotech, Inc. annual Operating Lease, Payments for 2022 was $129K, a 6.52% decline from 2021.
  • Moleculin Biotech, Inc. annual Operating Lease, Payments for 2021 was $138K, a 2.99% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $134K +$5K +3.88% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-22
2022 $129K -$9K -6.52% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 $138K +$4K +2.99% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $134K +$60K +81.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $74K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.